IMS Health Holdings Inc

IMS Health — Q2 2014 Earnings Presentation

19 slides from IMS Health's earnings presentation, Jul 24, 2014

  1. Slide 1: IMS Health Q2 2014 Earnings Call

    IMS Health Q2 2014 Earnings Call July 24, 2014 IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q2 2014 earnings call Safe Harbor Statement This presentation includes “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements rega

  3. Slide 3: 2nd Quarter Results

    2nd Quarter Results $M Revenue EBITDA +6.1% +9.2% $662 $226 $624 $206 Q2 2013 Q2 2014 Q2 2013 Q2 2014 Dollars are actual foreign exchange rates. EBITDA is “Adjusted EBITDA” as defined in the IMS Health earnings release IMS Health Confidential. Do not distribute outside your organization. 3 (c) 2014

  4. Slide 4: Progress in the Quarter

    Progress in the Quarter Cegedim’s Information Solutions and CRM Businesses Information Technology Services • Healthcare Professionals • CRM SaaS Solutions Database • Compliance Applications • Market Research 42% • Managed Services • Analytics 33% 25% Other(1) 2013 Financials(2) $573M Revenue, $86M A

  5. Slide 5: 2nd Quarter Revenue by Offering

    2nd Quarter Revenue Offering 2ndd Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Information $386 $379 1.8% 1.2% Technology $276 $245 12.7% 12.0% Services Total $662 $624 6.1% 5.4% IMS Health Confidential. Do not distribute outside your organization. 5 (c) 2014 IMS Health Incorpor

  6. Slide 6: 2nd Quarter Revenue by Geography

    2nd Quarter Revenue Geography 2nd Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Developed Markets $543 $515 5.5% 4.4% Emerging Markets $119 $109 8.7% 10.1% Total $662 $624 6.1% 5.4% IMS Health Confidential. Do not distribute outside your organization. 6 (c) 2014 IMS Health Incorp

  7. Slide 7: 2nd Quarter EBITDA

    2nd Quarter EBITDA 2nd Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Adjusted EBITDA $226 $206 9.2% 9.3% Adjusted EBITDA 34.0% 33.1% 97bps 123 bps margin g IMS Health Confidential. Do not distribute outside your organization. 7 (c) 2014 IMS Health Incorporated. All Rights Reserve

  8. Slide 8: Special Items - 2nd Quarter

    Special Items - 2nd Quarter 2nd Quarter, $M 2014 IPO related charges: g Sponsor monitoring termination $72 Non executive phantom stock compensation Non-executive $30 Make-whole premiums $151 Non-cash debt issuance & OID write-offs $68 Other charges: Devaluation of Venezuelan Bolivar assets & liabili

  9. Slide 9: 2nd Quarter P&L

    2nd Quarter P&L $M (except per share data) 2014 2013 Net (Loss) / Income $(220) $8 Adjusted Net Income $134 $96 Diluted (Loss) / Earnings per Share $(0.67) $0.03 Adjusted Diluted EPS $0.39 $0.33 IMS Health Confidential. Do not distribute outside your organization. 9 (c) 2014 IMS Health Incorporated.

  10. Slide 10: Year-to-date Revenue

    Year-to-date Revenue Offering Year-to-date Versus Prior Year Constant $M $ 2014 2013 Reported p C Currency Information $767 $757 1.4% 2.0% Technology $540 $480 12.3% 12.2% S Services i Total $1,307 $1,237 5.7% 6.0% Geography Year-to-date Versus Prior Year Developed Markets $1,075 $1,024 5.0% 4.8% Em

  11. Slide 11: Year-to-date P&L

    Year-to-date P&L $M (except per share data) 2014 2013 Adjusted EBITDA $443 $409 Adjusted EBITDA margin 33.9% 33.1% Net (Loss) / Income $(244) $20 Adjusted Net Income $204 $172 Diluted (Loss) / Earnings per Share $(0.80) $0.07 Adj t d Diluted Adjusted Dil t d EPS $0 65 $0.65 $0 60 $0.60 Year-to-date

  12. Slide 12: 2nd Quarter Balance Sheet Items & Metrics

    2nd Quarter Balance Sheet Items & Metrics $M 2014 2013 Cash & Cash Equivalents & Short Term $266 $729 ((1)) Investments Gross Debt (2) $3,996 $5,027 (1) Net Debt $3,730 $4,298 (1) Gross Leverage Ratio 4.6x 6.1x (1) Cash (Used in) Provided by Operating $(126) $126 Activities Capital Expenditures and

  13. Slide 13: Q&A

    Q&A IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.

  14. Slide 14: Appendix: Non-GAAP Financial Measures

    Appendix: Non-GAAP Financial Measures IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.

  15. Slide 15: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA Three Months Ended Six Months Ended June 30, June 30, (in millions) 2014 2013 2014 2013 Net (loss) income $ (220) $ 8 $ (244) $ 20 (Benefit from) provision for income taxes (139) 9 (152) 14 Other loss (income), net(1) 271 6 288 (10) Interest expense 49 75 138 154 Intere

  16. Slide 16: Net Income to Adjusted Net Income & Per Share Data

    Net Income to Adjusted Net Income & Per Share Data Three Months Ended Six Months Ended June 30, June 30, (in millions) 2014 2013 2014 2013 Net (Loss) Income $ (220) $ 8 $ (244) $ 20 (Benefit from) provision for income taxes (139) 9 (152) 14 Amortization associated with purchase accounting 77 75 153

  17. Slide 17: Unlevered Free Cash Flow

    Unlevered Free Cash Flow Three Months Ended Six Months Ended June 30, June 30, (in millions) 2014 2013 2014 2013 Net Cash (Used in) Provided by Operating Activities $ (126) $ 126 $ (229) $ 124 Capital expenditures (12) (10) (45) (17) Additions to computer software (23) (18) (44) (31) Free Cash Flow

  18. Slide 18: Gross Leverage Ratio

    Gross Leverage Ratio (in millions) Gross Debt as of June 30, 2014 $ 3,996 Adjusted EBITDA for the year ended December 31, 2013 829 Less: Adjusted EBITDA for the six months ended June 30, 2013 (409) Add: Adjusted EBITDA for the six months ended June 30 30, 2014 443 Adjusted EBITDA for the twelve mont

  19. Slide 19: END

    END IMS Health Confidential. Do not distribute outside your organization. 19 (c) 2014 IMS Health Incorporated. All Rights Reserved.

IMS Health — Q2 2014 Earnings Presentation on 6ix